Gene Specific Effects on Brain Volume and Cognition of in Frontotemporal Lobar Degeneration

Background And Objectives: has been proposed as a modifier of disease risk in FTLD-TDP, particularly in mutation carriers. Furthermore, has been investigated as a disease modifier in the context of healthy aging and across multiple neurodegenerative diseases. The objective of this study is to evaluate and compare the effect of on gray matter volume and cognition in each of the common genetic FTD groups and in sporadic FTD patients.

Methods: Participants were enrolled through the ARTFL/LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) study, which includes symptomatic and presymptomatic individuals with a pathogenic mutation in , symptomatic non-mutation carriers, and non-carrier family controls. All participants were genotyped for the rs1990622 SNP. Cross-sectionally, linear mixed-effects models were fitted to assess an association between and genetic group interaction with each outcome measure (gray matter volume and UDS3-EF for cognition), adjusting for education, age, sex and CDR+NACC-FTLD sum of boxes. Subsequently, associations between and each outcome measure were investigated within the genetic group. For longitudinal modeling, linear mixed-effects models with time by predictor interactions were fitted.

Results: The minor allele of rs1990622, linked to a decreased risk of FTD, associated with greater gray matter volume in mutation carriers under the recessive dosage model. This was most pronounced in the thalamus in the left hemisphere, with a retained association when considering presymptomatic mutation carriers only. The minor allele of rs1990622 also associated with greater cognitive scores among all mutation carriers and in presymptomatic mutation carriers, under the recessive dosage model.

Discussion: We identified associations of with gray matter volume and cognition in the presence of and mutations. This further supports as modifier of TDP-43 pathology. The association of with outcomes of interest in presymptomatic and mutation carriers could additionally reflect TMEM106B's impact on divergent pathophysiological changes before the appearance of clinical symptoms.

References

Gendron T, Heckman M, White L, Veire A, Pedraza O, Burch A . Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders. Cell Rep Med. 2022; 3(4):100607. PMC: 9044101. DOI: 10.1016/j.xcrm.2022.100607. View

Whitwell J, Boeve B, Weigand S, Senjem M, Gunter J, Baker M . Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images. Eur J Neurol. 2015; 22(5):745-52. PMC: 4390434. DOI: 10.1111/ene.12675. View

Lattante S, Le Ber I, Galimberti D, Serpente M, Rivaud-Pechoux S, Camuzat A . Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations and C9orf72 repeat expansions. Neurobiol Aging. 2014; 35(11):2658.e1-2658.e5. DOI: 10.1016/j.neurobiolaging.2014.06.023. View

Finch N, Carrasquillo M, Baker M, Rutherford N, Coppola G, DeJesus-Hernandez M . TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology. 2010; 76(5):467-74. PMC: 3034409. DOI: 10.1212/WNL.0b013e31820a0e3b. View

Staffaroni A, Asken B, Casaletto K, Fonseca C, You M, Rosen H . Development and validation of the Uniform Data Set (v3.0) executive function composite score (UDS3-EF). Alzheimers Dement. 2020; 17(4):574-583. PMC: 8044003. DOI: 10.1002/alz.12214. View

Casaletto K, Kornack J, Paolillo E, Rojas J, VandeBunte A, Staffaroni A . Association of Physical Activity With Neurofilament Light Chain Trajectories in Autosomal Dominant Frontotemporal Lobar Degeneration Variant Carriers. JAMA Neurol. 2022; 80(1):82-90. PMC: 9664369. DOI: 10.1001/jamaneurol.2022.4178. View

Harding S, Bocchetta M, Gordon E, Cash D, Cardoso M, Druyeh R . The TMEM106B risk allele is associated with lower cortical volumes in a clinically diagnosed frontotemporal dementia cohort. J Neurol Neurosurg Psychiatry. 2017; 88(11):997-998. PMC: 5740537. DOI: 10.1136/jnnp-2017-315641. View

Van Deerlin V, Sleiman P, Martinez-Lage M, Chen-Plotkin A, Wang L, Graff-Radford N . Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010; 42(3):234-9. PMC: 2828525. DOI: 10.1038/ng.536. View

Ashburner J, Friston K . Unified segmentation. Neuroimage. 2005; 26(3):839-51. DOI: 10.1016/j.neuroimage.2005.02.018. View

10.

Vass R, Ashbridge E, Geser F, Hu W, Grossman M, Clay-Falcone D . Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis. Acta Neuropathol. 2010; 121(3):373-80. PMC: 3095217. DOI: 10.1007/s00401-010-0782-y. View

11.

Rhinn H, Abeliovich A . Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes. Cell Syst. 2017; 4(4):404-415.e5. DOI: 10.1016/j.cels.2017.02.009. View

12.

Lui H, Zhang J, Makinson S, Cahill M, Kelley K, Huang H . Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation. Cell. 2016; 165(4):921-35. PMC: 4860138. DOI: 10.1016/j.cell.2016.04.001. View

13.

van der Zee J, Van Langenhove T, Kleinberger G, Sleegers K, Engelborghs S, Vandenberghe R . TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain. 2011; 134(Pt 3):808-15. PMC: 3044834. DOI: 10.1093/brain/awr007. View

14.

Dugan A, Nelson P, Katsumata Y, Shade L, Boehme K, Teylan M . Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study. Acta Neuropathol Commun. 2021; 9(1):152. PMC: 8442328. DOI: 10.1186/s40478-021-01250-2. View

15.

White C, Yang H, Yu L, Chibnik L, Dawe R, Yang J . Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data. PLoS Med. 2017; 14(4):e1002287. PMC: 5404753. DOI: 10.1371/journal.pmed.1002287. View

16.

Nelson P, Wang W, Partch A, Monsell S, Valladares O, Ellingson S . Reassessment of risk genotypes (GRN, TMEM106B, and ABCC9 variants) associated with hippocampal sclerosis of aging pathology. J Neuropathol Exp Neurol. 2014; 74(1):75-84. PMC: 4270894. DOI: 10.1097/NEN.0000000000000151. View

17.

Manini A, Ratti A, Brusati A, Maranzano A, Fogh I, Peverelli S . Acts as a Modifier of Cognitive and Motor Functions in Amyotrophic Lateral Sclerosis. Int J Mol Sci. 2022; 23(16). PMC: 9408885. DOI: 10.3390/ijms23169276. View

18.

Ashburner J, Friston K . Diffeomorphic registration using geodesic shooting and Gauss-Newton optimisation. Neuroimage. 2011; 55(3):954-67. PMC: 3221052. DOI: 10.1016/j.neuroimage.2010.12.049. View

19.

Rostgaard N, Roos P, Budtz-Jorgensen E, Johannsen P, Waldemar G, Norremolle A . TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3). Neurobiol Aging. 2017; 59:221.e1-221.e7. DOI: 10.1016/j.neurobiolaging.2017.06.026. View

20.

Sled J, Zijdenbos A, Evans A . A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging. 1998; 17(1):87-97. DOI: 10.1109/42.668698. View